Analysts have lowered their price targets on Docebo, and our fair value estimate has been revised from about CA$42.80 to roughly CA$35.10. This adjustment reflects expectations of softer subscription growth, contract headwinds and a lower assumed future P/E multiple, partially offset by stronger modeled profit margins.
Analyst Commentary
Street research on Docebo has turned more cautious overall, with several firms trimming price targets while maintaining mixed views on the company’s execution and growth setup. For you as an investor, the key debate centers on how temporary current headwinds are and how much of that is already reflected in the share price.
Bullish Takeaways
- Bullish analysts highlight one of Docebo’s strongest gross bookings quarters since 2021, which they view as a sign that underlying demand for the platform may be healthier than headline metrics suggest.
- Some see the core business as structurally sound, arguing that current reported figures may understate the health of the subscription base, which matters for any long term growth and margin story.
- Despite lower price targets, supportive analysts keep positive ratings in place, indicating they still see room for execution to support the current valuation over time if management delivers on growth and profitability plans.
- There is an expectation among more optimistic voices that growth trends could improve in the second half. If this occurs, it could help justify current earnings multiples even after lower target prices.
Bearish Takeaways
- Bearish analysts are resetting expectations with reduced price targets in the mid US$20s, reflecting higher caution on what they are willing to pay for the stock relative to current fundamentals.
- There is concern around softer organic subscription growth in the near term, which directly pressures the growth case and can make the current P/E multiple look more demanding.
- Contract related headwinds, including the AWS contract roll off and ongoing Dayforce churn, are viewed as meaningful overhangs on reported revenue and bookings, raising questions about the pace of growth normalization.
- Some more cautious views describe Docebo as a “show me story.” In practice, this means investors may want to see a few more quarters of consistent execution before assigning a higher valuation or assuming a smoother growth path.
What's in the News
- The Board of Directors authorized a new share buyback plan on January 29, 2026, signaling an intention to repurchase shares under a substantial issuer bid (Key Developments).
- Docebo launched a substantial issuer bid to repurchase up to 2,941,176 shares, or 10.23% of its shares, for US$60 million at US$20.40 per share, funded by cash on hand and its credit facility, with the offer set to expire on March 10, 2026 unless changed (Key Developments).
- The company provided revenue guidance for the fourth quarter of 2025, calling for total revenue between US$62.7 million and US$63 million, compared with US$57 million in the fourth quarter of 2024 (Key Developments).
- For the fiscal year ended December 31, 2026, Docebo issued total revenue guidance in a range of US$267.5 million to US$269.5 million (Key Developments).
- Between October 1, 2025 and December 31, 2025, Docebo reported no additional repurchases under its May 9, 2025 buyback and stated that it had completed the program with 954,967 shares repurchased for CA$38.32 million, representing 3.23% of shares (Key Developments).
Valuation Changes
- Fair Value: Revised from about CA$42.80 to roughly CA$35.10, a reduction of around 18% in the modeled estimate.
- Discount Rate: Adjusted slightly higher from 7.61% to about 7.70%, implying a modestly higher required return in the model.
- Revenue Growth: Trimmed in the model from roughly 11.10% to about 10.61%, indicating slightly more conservative dollar growth assumptions.
- Net Profit Margin: Increased in the forecast from about 14.51% to roughly 18.21%, reflecting higher expected profitability in future years.
- Future P/E: Lowered in the assumptions from about 21.5x to roughly 14.0x, a sizeable step down in the multiple applied to earnings.
Have other thoughts on Docebo?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.